Discover 1,134 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
for
Episodic Migraine
Location: Stamford CT, Norfolk VA, Ajax, London, Akron OH,
Sponsor: H. Lundbeck A/S
Sex: All
Age: 6 - 17
Code: NCT05897320
Phase 3, Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Stamford CT, Philadelphia PA, Foxborough MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07589595
Phase 2, Recruiting
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Stamford CT, New York NY, Willow Grove PA,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase 2, Phase 3, Recruiting
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Stamford CT, Lebanon NH, Tampa FL, Pembroke Pines FL,
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18+
Code: NCT06752356
Phase 3, Recruiting
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
Get alerts for new trials in your area by subscribing now
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Stamford CT, Westbury NY, West Haven CT, Camden NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
for
Chronic Migraine in Children
Location: Stamford CT, Norfolk VA, Ajax, London, Huntington WV,
Sponsor: H. Lundbeck A/S
Sex: All
Age: 12 - 17
Code: NCT04965675
Phase 3, Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Stamford CT, Morristown NJ, Philadelphia PA, Nashua NH,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Stamford CT, Commack NY, Great Neck NY, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Stamford CT, Commack NY, New York NY, Cromwell CT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Stamford CT, Trumbull CT, Greenwich CT, Harrison NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung